Study of Gender-based In-Hospital Mortality Difference in Patients with Acute Myocardial Infarction

Autor: TA Choudhury, M Atahar Ali, Khan, Nupur Kar, GM Faruque, NK Majumder, M Akhtaruzzaman

Publikováno v: Bangladesh Heart Journal. 32:119-124

Background: In-hospital mortality in female patients with acute myocardial infarction (AMI) and factors affecting this may be different from those of their male counterpart. The aim of the current study was to compare the in-hospital mortality betwee

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d0f80a8b1bb3ed08d9cfb2c80826fb8a
https://doi.org/10.3329/bhj.v32i2.36099

Comparative study of coronary collaterals in diabetic and nondiabetic patients by angiography

Autor: A S Majumder, A. K. M. Anisur Rahman, WA Chowdhury, A Ali, GM Faruque, M Jalaluddin, M M Islam, M Faruque, N A Khan

Publikováno v: Mymensingh Medical Journal. 15

Myocardial ischaemia is known to be significantly related to the development of coronary collaterals, but there are considerable variations in their formation. The nature of this variability is not well understood. Likewise it remains unclear whether

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24a6c0d6d48f54c0c042a8d51c390d57
https://doi.org/10.3329/mmj.v15i2.38

A comparison of the efficacy of Olopatadine hydrochloride 0.1% ophthalmic solution and Sodium Chromoglycate ophthalmic solution in the treatment of allergic conjunctivitis

Autor: GM Faruque, Aqmo Sharif, Aima Uddin

Publikováno v: Journal of Dhaka Medical College. 18:136-139

Aim: To find out an effective drug for the treatment of allergic conjunctivitis and to compare the efficacy of Sodium chromoglycate ophthalmic solution and Olopatadine Hydrochloride 0.1% ophthalmic solution in the treatment of allergic conjunctivitis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d6cdde258e50cf916bf5a211805c79fb
https://doi.org/10.3329/jdmc.v18i2.6274

Ice Pack Test - An Alternate to Prostigmin Test in the Diagnosis of Myasthenia Gravis with Ocular Involvement: A Simple, Noninvassive and Safe Method

Autor: GM Faruque, Aqmo Sharif, Aim Anisuddin, TA Zafarullah, MF Kabir

Publikováno v: Journal of Dhaka Medical College. 18:112-114

Myasthenia gravis (MG) is the most frequent neuromuscular transmission disorder with incidence of 2-20 patients per million1. Its pathophysiology is autoimmune, with acetylcholine receptors (AChR) autoantibodies damaging the post-synaptic fold at the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1685acc098c92665352e2f2f2c52bade
https://doi.org/10.3329/jdmc.v18i2.6268

Global radiotherapy demands and corresponding radiotherapy-professional workforce requirements in 2022 and predicted to 2050: a population-based study.

Autor: Zhu H; Department of Radiation Oncology, Shanghai Cancer Center and Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; Shanghai Clinical Research Center for Radiation Oncology, Shanghai Key Laboratory of Radiation Oncology, Shanghai, China., Chua MLK; Division of Radiation Oncology and Precision Radiotherapeutics and Oncology Programme, Division of Medical Sciences, National Cancer Centre Singapore, Singapore; Medical School, Duke-National University of Singapore, Singapore., Chitapanarux I; Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand., Kaidar-Person O; Breast Cancer Radiation Therapy Unit, Sheba Medical Center, Ramat Gan, Israel; School of Medicine, Tel-Aviv University, Tel-Aviv, Israel; Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, Netherlands., Mwaba C; Department of Oncology, Cancer Diseases Hospital, Lusaka, Zambia., Alghamdi M; Radiation Oncology, Princess Noorah Oncology Center, King Abdulaziz Medical City, Ministry of National Guard Health Affairs-Western Region, Jeddah, Saudi Arabia; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia., Rodríguez Mignola A; Department of Radiation Oncology, Hospital Universitario Center for Medical Education and Clinical Research Norberto Quirno and Instituto Roffo, Buenos Aires, Argentina., Amrogowicz N; First Radiation and Clinical Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland., Yazici G; Department of Radiation Oncology, Medical School, Hacettepe University, Ankara, Türkiye., Bourhaleb Z; Mohammed VI Center for Cancer Treatment, Ibn Rochd University Hospital, Casablanca, Morocco., Mahmood H; Department of Clinical Oncology and Radiology, Nuclear Medicine, Oncology and Radiotherapy Institute, Atomic Energy Cancer Hospital, Islamabad, Pakistan., Faruque GM; Bangladesh Cancer Society, Dhaka, Bangladesh., Thiagarajan M; Department of Radiotherapy and Oncology, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia., Acharki A; Ryad Oncologia Clinic, Casablanca, Morocco., Ma M; Department of Radiation Oncology, Peking University First Hospital, Beijing, China., Harutyunyan M; Yeolyan Hematology and Oncology Center, Yerevan, Armenia., Sriplung H; Department of Epidemiology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand., Chen Y; Department of Epidemiology and Public Health, University College London, London, UK., Camacho R; City Cancer Challenge, Geneva, Switzerland., Zhang Z; Department of Radiation Oncology, Shanghai Cancer Center and Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; Shanghai Clinical Research Center for Radiation Oncology, Shanghai Key Laboratory of Radiation Oncology, Shanghai, China. Electronic address: zhen_zhang@fudan.edu.cn., Abdel-Wahab M; Division of Human Health, International Atomic Energy Agency, Vienna, Austria. Electronic address: m.abdel-wahab@iaea.org.

Publikováno v: The Lancet. Global health [Lancet Glob Health] 2024 Dec; Vol. 12 (12), pp. e1945-e1953. Date of Electronic Publication: 2024 Oct 11.